Table: Immuno Biological Lab -2021/22 group forecast
Mar 15 (Reuters) -
Immuno Biological Laboratories Co Ltd
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Mar 31, 2022 Mar 31, 2022
LATEST PREVIOUS
FORECAST FORECAST
Sales 645 mln 770 mln
Operating loss 128 mln loss 107 mln
Recurring loss 246 mln loss 154 mln
Net loss 255 mln loss 162 mln
EPS loss 27.37 yen loss 17.42 yen
NOTE - Immuno Biological Laboratories Co Ltd.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4570.T